Showing results (251-260 of 624) with videos related to
Sort By:
Pageof 63
Proceedings of the National Academy of Sciences of the United States of America|October 30, 2016
Differential growth triggers mechanical feedback that elevates Hippo signalingYuanwang Pan, Idse Heemskerk, Consuelo Ibar, et al.The British Journal of Dermatology|May 18, 2006
Dermatological manifestations of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy syndromeS M Collins, M Dominguez, T Ilmarinen, et al.Current Biology : CB|June 26, 2012
Propagation of Dachsous-Fat planar cell polarityAbhijit A Ambegaonkar, Guohui Pan, Madhav Mani, et al.Seminars in Cutaneous Medicine and Surgery|August 16, 2016
Update on Epidemiology, Diagnosis, and Disease Course of Atopic DermatitisEric L Simpson, Alan D Irvine, Lawrence F Eichenfield, et al.Seminars in Cutaneous Medicine and Surgery|August 16, 2016
Review of Critical Issues in the Pathogenesis of Atopic DermatitisAlan D Irvine, Lawrence F Eichenfield, Sheila F Friedlander, et al.Seminars in Cutaneous Medicine and Surgery|August 16, 2016
Assessing the New and Emerging Treatments for Atopic DermatitisLawrence F Eichenfield, Sheila F Friedlander, Eric L Simpson, et al.Antimicrobial Agents and Chemotherapy|August 1, 1995
OXA-14, another extended-spectrum variant of OXA-10 (PSE-2) beta-lactamase from Pseudomonas aeruginosaF Danel, L M Hall, D Gur, et al.Heredity|June 17, 2010
Pollen-mediated gene flow in flax (Linum usitatissimum L.): can genetically engineered and organic flax coexist?A J Jhala, H Bhatt, K Topinka, et al.Antimicrobial Agents and Chemotherapy|April 1, 1997
OXA-15, an extended-spectrum variant of OXA-2 beta-lactamase, isolated from a Pseudomonas aeruginosa strainF Danel, L M Hall, D Gur, et al.Antimicrobial Agents and Chemotherapy|December 3, 1998
OXA-16, a further extended-spectrum variant of OXA-10 beta-lactamase, from two Pseudomonas aeruginosa isolatesF Danel, L M Hall, D Gur, et al.Pageof 63